All Stories

  1. The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
  2. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis
  3. Outcome prediction model and prognostic biomarkers for COVID-19 patients in Vietnam
  4. Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
  5. Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam
  6. Prevalence and genetic basis of first-line drug resistance ofMycobacterium tuberculosisin Ca Mau, Vietnam
  7. A Direct Measure of Tuberculosis Incidence — Effect of Community Screening
  8. New definitions of extensively drug resistant tuberculosis: update from the World Health Organization
  9. New treatment outcome definitions for drug-susceptible and drug-resistant tuberculosis: update from World Health Organization
  10. World Health Organization treatment outcome definitions for tuberculosis: 2021 update
  11. New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
  12. Potential benefits of active case finding to reduce the burden of TB
  13. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
  14. A comparison of digital chest radiography and Xpert® MTB/RIF in active case finding for tuberculosis
  15. Is effective patient support missing in the global response to multidrug-resistant tuberculosis?
  16. An assessment of current tuberculosis patient care and support policies in high-burden countries
  17. No universal access to drug-resistant tuberculosis care without engaging all health care providers
  18. Community-wide Screening for Tuberculosis in a High-Prevalence Setting
  19. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
  20. Will regulatory issues continue to be a major barrier to access to bedaquiline and delamanid?
  21. The impact of digital health technologies on tuberculosis treatment: a systematic review
  22. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis
  23. The global response to rifampicin-resistant tuberculosis: Current situation and recent trends
  24. Multidrug-resistant tuberculosis around the world: what progress has been made?
  25. Building operational research capacity in the Pacific
  26. Tuberculosis patients’ knowledge and beliefs about tuberculosis: a mixed methods study from the Pacific Island nation of Vanuatu
  27. Traditional healers and the potential for collaboration with the national tuberculosis programme in Vanuatu: results from a mixed methods study
  28. The trend of tuberculosis cases over 60 years in Fiji′s largest treatment centre: 1950–2010
  29. Nurses graduating in Fiji between 2001 and 2010: sufficient supply for Fiji's health service demands?
  30. Sputum smear examination and time to diagnosis in patients with smear-negative pulmonary tuberculosis in the Pacific
  31. Molecular epidemiology of tuberculosis and recent developments in understanding the epidemiology of tuberculosis
  32. TUBERDIAG: AN EXPERT SYSTEM FOR PULMONARY TUBERCULOSIS DIAGNOSIS
  33. Designing an experimental expert system for lung tuberculosis diagnostics using fuzzy set theory